ARTICLE | Clinical News
GLPG0634: Phase I start
August 9, 2010 7:00 AM UTC
This week, Galapagos will begin a double-blind, placebo-controlled, Belgian Phase I trial to evaluate single and multiple ascending doses of oral GLPG0634 in at least 40 healthy volunteers. Last week,...